Thermo Fisher Launches CE-IVD Marked Assay to Detect Treatment-Resistant HIV Strains
Thermo Fisher Scientific launched its Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit, an assay that examines positive samples of HIV.
Thermo Fisher Scientific launched its Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit, an assay that examines positive samples of HIV.
Psomagen Incorporated and Kean Health announced the launch of Kean V and Kean V+, a vaginal microbiome test.
M. Genitalium testing is difficult, but the approval of a NAAT for the diagnosis of this STI will help protect patient fertility.
Visby Medical has received a 510(k) clearance to market its fast, single-use PCR diagnostic test for the detection of STIs.
Read MoreThe first national in-home HIV testing program centered around reaching communities disproportionately impacted by HIV has been launched.
Read MoreHologic, Inc. has commended the decision of the CDC to endorse an updated approach to screening for two of the most common STIs in the U.S.
Read MoreThe COVID-19 pandemic knocked many women off schedule for important health appointments including for cancer and STI screenings, a new study finds, and many didn’t get back on schedule even after clinics reopened.
Read MoreTechnology developed by UCL and AHRI researchers could transform the ability to accurately interpret HIV test results.
Read MoreThe campaign “My test, my way” is coordinated with the support of the CDC and seeks to encourage Latinos and Latinas of all ages to get tested for HIV.
Read MoreScreening and testing for sexually transmitted infections decreased by 63% for men and 59% for women during the early months of the COVID-19 pandemic, likely resulting in many missed cases, according to a new study.
Read MoreThe University of Chicago Medicine maintained screening volumes by including universal HIV screening alongside COVID-19 testing in its busy emergency department, according to a new report.
Read MoreIncreasing public awareness of the laboratory’s role in public health offers an opportunity to slow the spread of sexually transmitted infections.
Read MoreThe binx io provides results in about 30 minutes, which enables diagnosis and treatment of chlamydia and gonorrhea in a single visit.
Read MoreATCC joins the National Institute of Allergy and Infectious Diseases’ team working on preclinical services for HIV therapeutics.
Read MoreHologic’s Aptima HIV-1 Quant Dx assay is now the first dual-claim assay for both diagnosis and viral load monitoring in the United States.
Read MoreA multiplex assay based on high-resolution melting technology accurately identified antimicrobial resistant determinants in Neisseria gonorrhoeae.
Read MoreCINtec Plus Cytology is a triage test based on biomarker technology for women with positive cervical cancer screening results for high-risk types of HPV.
Read MoreThe test provides healthcare professionals with a single result to confirm HIV diagnosis and to differentiate HIV-1 and HIV-2.
Read More